comparemela.com

Fingolimod Capsules News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Aurobindo Pharma restarts aseptic product distribution; shares trade higher

The share touched a 52-week high of Rs 1,177.00 and a 52-week low of Rs 443.15 on 30 January, 2024 and 14 March, 2023, respectively.

Andhra pradeshNaidupeta mandalTenofovir disoproxil fumarateAurobindo pharmaNovartis pharmaceuticals corporationUnit inspection teamPrequalification assessment teamWorld health organizationUs food drug administrationEugia pharma specialities ltdPharma specialities ltdMenakuru villageTirupati districtTenofovir disoproxil fumarate tabletsDrug administrationFingolimod capsules

Aurobindo Pharma arm gets WHO GMP approval; shares flat

The Prequalification Unit Inspection Team (PQT-INS) of World Health organization (WHO) had conducted an inspection at the Unit IV from September 11 to September 15, 2023.

Andhra pradeshUnited statesTenofovir disoproxil fumarateNaidupeta mandalAurobindo pharmaNovartis pharmaceuticals corporationPvt ltdAurobindo pharma ltdPrequalification unit inspection teamPrequalification assessment teamDrug administrationUs food drug administrationWorld healthWorld health organizationMenakuru villageTirupati district

Glenmark Pharmaceuticals : Q4FY 2022-23

"Glenmark Pharmaceuticals Limited Q4 FY 23 Earnings Conference Call" May 22, 2023 MANAGEMENT: MR. GLENN. | May 24, 2023

Czech republicSouth koreaUnited statesUnited kingdomSri lankaRepublic ofHikma glenmarkUtkarsh gandhiGlenmark europeInvestor relations for glenmark pharmaceuticalsGlenmark pharmaceuticals incConference call of glenmark pharmaceuticalsYuhan corporationEarnings conference call of glenmark pharmaceuticalsGlenmark pharmaceuticalsPharmaceuticals limited

Glenmark Pharma launches Fingolimod Capsules in US market; Stock gains 2%

Glenmark’s current portfolio consists of 176 products authorized for distribution in the U.S. marketplace.

Sanjeev krishanStates glenmarkNovartis pharmaceuticals corporationGlenmark pharmaceuticals incGlenmark pharmaceuticals ltdUnited statesFingolimod capsulesGilenya capsulesNovartis pharmaceuticalsGlenmark north america

Glenmark Pharmaceuticals launches Fingolimod Capsules, 0 5 mg in the US

Glenmark Pharmaceuticals Inc., USA has launched their Fingolimod Capsules, 0.5 mg, the generic version of Gilenya® Capsules, 0.5 mg, of Novartis Pharmaceuticals Corporation.

Sanjeev krishanStates glenmarkNovartis pharmaceuticals corporationGlenmark pharmaceuticalsGlenmark pharmaceuticals incFingolimod capsulesPharmaceuticals incUnited statesNovartis pharmaceuticalsGlenmark north americaGlenmark pharmaceuticals limited

vimarsana © 2020. All Rights Reserved.